Marianne J Chapman Selected Research

Enteral Nutrition (Feeding, Tube)

1/2021	Use of a High-Protein Enteral Nutrition Formula to Increase Protein Delivery to Critically Ill Patients: A Randomized, Blinded, Parallel-Group, Feasibility Trial.
1/2021	Blinded, Double-Dummy, Parallel-Group, Phase 2a Randomized Clinical Trial to Evaluate the Efficacy and Safety of a Highly Selective 5-Hydroxytryptamine Type 4 Receptor Agonist in Critically Ill Patients With Enteral Feeding Intolerance.
12/2020	Energy-dense vs routine enteral nutrition in New Zealand Europeans, Māori, and Pacific Peoples who are critically ill.
1/2020	Outcomes Six Months after Delivering 100% or 70% of Enteral Calorie Requirements during Critical Illness (TARGET). A Randomized Controlled Trial.
1/2019	Energy-Dense versus Routine Enteral Nutrition in the Critically Ill.
1/2018	Nutrition Adequacy Therapeutic Enhancement in the Critically Ill: A Randomized Double-Blind, Placebo-Controlled Trial of the Motilin Receptor Agonist Camicinal (GSK962040): The NUTRIATE Study.
10/2016	Pantoprazole or Placebo for Stress Ulcer Prophylaxis (POP-UP): Randomized Double-Blind Exploratory Study.
9/2016	Critical Illness Is Associated With Impaired Gallbladder Emptying as Assessed by 3D Ultrasound.
1/2016	Energy-Dense Formulae May Slow Gastric Emptying in the Critically Ill.
11/2015	Effect of Critical Illness on Triglyceride Absorption.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marianne J Chapman Research Topics

Disease

61	Critical Illness (Critically Ill) 01/2022 - 07/2005
6	Septic Shock (Toxic Shock Syndrome) 11/2019 - 03/2009
6	Type 2 Diabetes Mellitus (MODY) 11/2019 - 01/2009
3	Diarrhea 01/2021 - 06/2012
3	Hypoglycemia (Reactive Hypoglycemia) 01/2021 - 06/2014
3	Inflammation (Inflammations) 11/2019 - 01/2016
3	Sepsis (Septicemia) 11/2019 - 01/2016
3	Hyperglycemia 01/2016 - 10/2013
2	Infections 06/2017 - 12/2011
2	Bacterial Infections (Bacterial Infection) 01/2017 - 01/2008
1	Muscular Atrophy (Muscle Atrophy) 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021
1	Bacteremia 11/2019
1	Ileus 02/2019
1	Brain Death (Brain Dead) 12/2018
1	Brain Injuries (Brain Injury) 01/2018
1	Wounds and Injuries (Trauma) 01/2018
1	Human Influenza (Influenza) 01/2017
1	Constipation 01/2017
1	Respiratory Insufficiency (Respiratory Failure) 01/2017
1	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2016
1	Pneumonia (Pneumonitis) 10/2016
1	Ulcer 10/2016
1	Hemorrhage 10/2016
1	Clostridium Infections 10/2016
1	Cough 08/2016
1	Craniocerebral Trauma (Head Injury) 01/2016
1	Oliguria 01/2016
1	Burns 05/2015

Drug/Important Bio-Agent (IBA)

19	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2009
11	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2017 - 01/2009
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2015
9	Blood Glucose (Blood Sugar)IBA 03/2017 - 01/2009
7	Erythromycin (Erycette)FDA LinkGeneric 02/2019 - 07/2005
5	Insulin (Novolin)FDA Link 01/2021 - 01/2009
4	Metoclopramide (Reglan)FDA LinkGeneric 01/2021 - 02/2007
3	Peptides (Polypeptides)IBA 01/2015 - 01/2010
3	Cholecystokinin (Pancreozymin)IBA 05/2008 - 01/2007
2	Pharmaceutical PreparationsIBA 01/2021 - 06/2012
2	AntibodiesIBA 11/2019 - 01/2017
2	HMGB1 Protein (HMG1)IBA 11/2019 - 01/2017
2	N- (3- fluorophenyl)- 1- ((4- (((3S)- 3- methyl- 1- piperazinyl)methyl)phenyl)acetyl)- 4- piperidinamineIBA 01/2018 - 01/2016
2	AcidsIBA 10/2016 - 10/2010
2	Oxygen (Dioxygen)IBA 08/2016 - 01/2016
2	MotilinIBA 01/2016 - 01/2010
2	LipidsIBA 11/2015 - 06/2012
2	IncretinsIBA 02/2014 - 01/2010
2	Glucagon (Glukagon)FDA Link 05/2010 - 01/2009
2	Hormones (Hormone)IBA 01/2010 - 05/2008
2	Peptide YYIBA 05/2008 - 01/2007
1	ElementsIBA 01/2022
1	Amino Acids FDA Link 01/2022
1	Muscle Proteins (Muscle Protein)IBA 01/2022
1	Dietary ProteinsIBA 01/2022
1	CarbohydratesIBA 01/2021
1	Serotonin (5 Hydroxytryptamine)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2019
1	Opiate AlkaloidsIBA 01/2018
1	motilin receptorIBA 01/2018
1	CytokinesIBA 01/2017
1	Oseltamivir (Tamiflu)FDA Link 01/2017
1	Neuraminidase (Sialidase)IBA 01/2017
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2017
1	Zanamivir (Relenza)FDA Link 01/2017
1	Hemoglobins (Hemoglobin)IBA 10/2016
1	Pantoprazole (Protonix)FDA LinkGeneric 10/2016
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2016
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2016
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2016
1	CreatinineIBA 01/2016
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2016
1	Triglycerides (Triacylglycerol)IBA 11/2015
1	SolutionsIBA 08/2014
1	Dipeptidyl-Peptidase IV InhibitorsIBA 02/2014
1	SodiumIBA 01/2014
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2014
1	Tramadol (K315)FDA LinkGeneric 01/2014
1	Sodium-Glucose Transport ProteinsIBA 01/2014
1	salicylhydroxamic acid (SHAM)IBA 01/2014
1	Sucrose (Saccharose)IBA 05/2013
1	RhamnoseIBA 05/2013
1	DisaccharidasesIBA 05/2013
1	Lactulose (Duphalac)FDA LinkGeneric 05/2013
1	cyclo(Arg-Pro) (CI 4)IBA 12/2011

Therapy/Procedure

23	Enteral Nutrition (Feeding, Tube) 01/2021 - 04/2007
10	Therapeutics 11/2019 - 02/2007
6	Critical Care (Surgical Intensive Care) 01/2020 - 09/2007
4	Nutritional Support (Artificial Feeding) 06/2017 - 08/2007
3	Intravenous Infusions 06/2015 - 01/2009
3	Catheters 05/2013 - 09/2007
2	Glycemic Control 01/2021 - 01/2016
2	Artificial Respiration (Mechanical Ventilation) 06/2017 - 09/2009
2	Ligation 01/2017 - 01/2014
2	Punctures 01/2017 - 01/2014
1	Drug Therapy (Chemotherapy) 02/2019
1	Wearable Electronic Devices 09/2017
1	Mechanical Ventilators (Ventilator) 10/2016
1	Laparotomy 01/2014
1	Nutrition Therapy (Medical Nutrition Therapy) 06/2012
1	Length of Stay 12/2011